In patients with an EVD to drain excess fluid from around the brain, current practice in terms of temporarily clamping the drain does not provide sufficient time to reach the true ICP level in most cases, according to the new research by Xiuyun Liu, PhD, and colleagues of University of California, San Francisco.
Three-Fourths of EVD Closures Don’t Leave Enough Time to Reach Stable ICP
The researchers evaluated procedures for ICP measurement via EVD in patients with subarachnoid hemorrhage (SAH). Subarachnoid hemorrhage is a severe type of stroke in which there is bleeding into the brain, most commonly caused by a ruptured aneurysm. Patients with SAH, traumatic brain injury, and certain other conditions are at risk of developing excessive pressure within the skull, which can cause secondary brain injury.
For these patients, surgical placement of an EVD within the ventricle is a lifesaving procedure, allowing drainage of cerebrospinal fluid (CSF) to control pressure within the skull. Regular and precise measurement of ICP is essential for clinicians to make decisions promptly to protect the brain. To perform these measurements, the EVD system must be temporarily clamped. This stops CSF drainage, allowing the true level of ICP within the brain to be reached.
A 2017 study in JNN suggested that a minimum 5-minute period without drainage is required to reach equilibrium, or a stable level of ICP. “This clinical practice still faces great challenges,” the researchers write. “[R]ecent studies have revealed wide practice variations associated with monitoring, treating, and documenting ICP values using EVD.”
Is the 5-minute waiting period long enough to reach a stable ICP level? To find out, Dr. Liu and colleagues analyzed high-resolution continuous ICP values recorded via EVD in 107 patients with SAH. The analysis included data from every clamping procedure performed throughout the patients’ hospital stay: a total of nearly 33,000 episodes of EVD closure. The researchers developed an automated algorithm to determine whether EVD clamping times allowed enough time for ICP to reach a new equilibrium.
About 66 percent of EVD closures were less than one minute, while 16 percent were more than five minutes. Some closures were performed to test whether the patient was ready to be weaned off their EVD –whether their ICP remained under control without CSF drainage. In about 30 percent of tests, the patient was not yet ready for weaning.
Overall, just 23 percent of closures met study criteria for equilibrium, including a stable ICP level with an EVD closure time of longer than one minute. This suggested that more than three-fourths of EVD closures may not have left adequate time for accurate ICP measurement.
“The result is crucial, and it raises great concerns about the current practice of clamping EVD to measure ICP and obtain accurate readings,” Dr. Liu and coauthors write. “A standard guideline and proper training to nurses are needed for ICP intermittent checking.” The researchers also call for continued innovations in monitoring technology that can quickly and accurately show ICP trends at a “proper time scale,” alongside other critical vital signs.
DOI: 10.1097/JNN.0000000000000487
###
About the Journal of Neuroscience Nursing
The Journal of Neuroscience Nursing (JNN), the official journal of the American Association of Neuroscience Nurses, contains original articles on advances in neurosurgical and neurological techniques as they affect nursing care, theory and research, as well as commentary on the roles of the neuroscience nurse in the health care team.
The journal provides information to nurses and health care professionals working in diverse areas of neuroscience patient care. The information is applicable to professionals working in clinical, research, administrative, and educational settings.
About the American Association of Neuroscience Nurses
Founded in 1968, the American Association of Neuroscience Nurses (AANN) is an organization of more than 5,400 nurses and healthcare professionals worldwide. These professionals work in clinical, research, administrative, and educational settings, covering diverse areas of neuroscience patient care such as multispecialty and neuroscience intensive care units, general neuroscience units, combination units, rehabilitation units, medical-surgical units, pediatric units, emergency and trauma departments, and surgery.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2018 annual revenues of €4.3 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 18,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
Original post https://alertarticles.info